Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
G1 Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $2.51 | Sep 18, 2024 | Direct |
Day One Biopharmaceuticals, Inc. | Director | Director Stock Option (Right to buy Common Stock) | 37.5K | Jun 22, 2023 | Direct | ||
Day One Biopharmaceuticals, Inc. | Director | Stock Option (right to buy Common Stock) | 32.3K | May 23, 2024 | Direct | ||
TScan Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 23.8K | Jun 12, 2024 | Direct | ||
NextCure, Inc. | Director | Stock Option (Right to Buy) | 14.3K | Jun 22, 2023 | Direct | ||
G1 Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Sep 18, 2024 | Direct | ||
Turning Point Therapeutics, Inc. | Director | Stock Option (right to buy) | 0 | Aug 17, 2022 | Direct |